BPC-157, TB-500 20mg (Blend)

Description

BPC-157, also known as Pentadecapeptide BPC-157 or Body Protection Compound 157, is a fully synthetic peptide studied for its potential involvement in various cellular processes. Research suggests it may interact with cellular signaling pathways related to tissue response and recovery in experimental injury models. Some studies indicate it could influence angiogenesis (blood vessel formation) and inflammatory signaling, as well as support cellular protection and regeneration. It has been explored in research settings for its potential role in supporting joint, tendon, muscle, and nerve tissue models.

TB-500, a synthetic form of thymosin beta-4 (TB-4), is another peptide investigated for its role in cellular repair processes. Derived from the naturally occurring thymosin beta-4 peptide encoded by the TMSB4X gene, TB-500 has been studied for its potential to influence cell migration, differentiation, and tissue regeneration. Research models suggest it may play a role in wound repair, angiogenesis, and cellular renewal, including in neurological and soft tissue contexts.

Both BPC-157 and TB-500 are synthetic polypeptides, with BPC-157 consisting of 15 amino acids and TB-500 consisting of 43 amino acids.

Based on thymosin beta-4 (Tβ4) research, TB-500 is suggested to influence cellular motility by increasing actin protein activity. It is proposed to regulate the actin cytoskeleton and cell migration through interactions with G-actin. A specific amino acid sequence [(17)LKKTETQ(23)] is believed to play a role in actin binding, potentially enhancing cell movement and contributing to wound repair processes. Additionally, TB-500 has been associated with increased levels of microRNA-146a (miR-146a), which may act as a regulator of certain inflammatory signaling pathways, including those involving IRAK1 and TRAF6. These findings suggest TB-500 may also exhibit anti-inflammatory properties in research models.

BPC-157 has been studied for its potential involvement in multiple biological pathways, including nitric oxide (NO) signaling, cellular repair mechanisms, growth factor activity, and inflammatory responses. Research suggests it may interact with NO pathways, potentially supporting endothelial function and promoting angiogenesis through the formation of new blood vessels. It has also been linked to the expression of the early growth response 1 (EGR1) gene, which may contribute to cytokine production, growth signaling, and early extracellular matrix formation, including collagen. Additionally, interactions with nerve growth factor-related pathways may influence regulatory processes at the cellular level. These combined actions may support tissue repair and regeneration in experimental settings.

Given that TB-500 and BPC-157 appear to exhibit complementary mechanisms in research models, their combined use has been suggested to potentially enhance overall effects compared to either compound alone.

Reference

https://pubmed.ncbi.nlm.nih.gov/?term=bpc-157
https://pubmed.ncbi.nlm.nih.gov/38382158

• • • • • • • • • • • • • • •  PLEASE READ • • • • • • • • • • • • • • •

RESEARCH USE ONLY DISCLAIMER AND LIMITATION OF LIABILITY

All articles, materials, content, and product-related information made available on this website are provided strictly for informational and educational purposes only and shall not be construed as medical, pharmaceutical, clinical, or therapeutic advice, nor as a representation of safety or efficacy for any human or animal use.

These products are not drugs, pharmaceuticals, biologics, medical devices, dietary supplements, food products, or cosmetics, and they have not been evaluated, approved, or authorized by the United States Food and Drug Administration (FDA) or any other regulatory authority for human or animal use.

The Company reserves all rights and expressly disclaims any liability arising from misuse, improper handling, or unauthorized application of its products.